Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentnpBAF complex

ARID1A SS18

2.45e-0414352GO:0071564
Domain-

PCBP1 KHDC4

2.29e-03393423.30.1370.10
DomainSET

KMT2B KMT5B

2.52e-0341342PF00856
DomainKH_dom_type_1

PCBP1 KHDC4

2.90e-0344342IPR004088
DomainSET

KMT2B KMT5B

3.17e-0346342SM00317
DomainSET_dom

KMT2B KMT5B

3.73e-0350342IPR001214
DomainSET

KMT2B KMT5B

3.73e-0350342PS50280
DomainIF

KRT76 LZTS3

8.43e-0376342IPR001664
Pubmed

HES1 is a novel downstream modifier of the SHH-GLI3 Axis in the development of preaxial polydactyly.

GLI1 ACAN ALX4

1.23e-062135334928956
Pubmed

Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation.

ARID1A TP53BP1

2.95e-06335236344675
Pubmed

Arid1a-Plagl1-Hh signaling is indispensable for differentiation-associated cell cycle arrest of tooth root progenitors.

ARID1A GLI1

5.90e-06435233826897
Pubmed

Gli1+ progenitors mediate bone anabolic function of teriparatide via Hh and Igf signaling.

GLI1 ACAN

9.82e-06535234407400
Pubmed

gp130/STAT3 signaling is required for homeostatic proliferation and anabolism in postnatal growth plate and articular chondrocytes.

GLI1 ACAN

1.47e-05635235039652
Pubmed

A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse.

KMT5B TP53BP1

1.47e-05635218676810
Pubmed

Genetic analysis of Hedgehog signaling in ventral body wall development and the onset of omphalocele formation.

GLI1 ALX4

1.47e-05635221283718
Pubmed

Expression of the mouse Gli and Ptc genes is adjacent to embryonic sources of hedgehog signals suggesting a conservation of pathways between flies and mice.

GLI1 ALX4

2.06e-0573529152005
Pubmed

Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.

ARID1A SS18

2.06e-05735223540691
Pubmed

A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4.

KMT2B TP53BP1

2.06e-05735219433796
Pubmed

Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.

MMP7 ACAN

2.06e-0573528216228
Pubmed

Skeletal growth is enhanced by a shared role for SOX8 and SOX9 in promoting reserve chondrocyte commitment to columnar proliferation.

GLI1 ACAN

2.74e-05835238346197
Pubmed

Intraflagellar transport is essential for endochondral bone formation.

GLI1 ACAN

2.74e-05835217166921
Pubmed

A census of human transcription factors: function, expression and evolution.

ZNF711 AKNA TCF3 GLI1 ALX4 CREB5 RXRG

2.87e-0590835719274049
Pubmed

Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.

KMT2B ARID1A TP53BP1

2.92e-055935328813667
Pubmed

A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.

KMT2B ARID1A SS18

3.23e-056135320305087
Pubmed

The mouse polydactylous mutation, luxate (lx), causes anterior shift of the anteroposterior border in the developing hindlimb bud.

GLI1 ALX4

3.53e-05935212455637
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

SH3BP1 SORBS1 LZTS3 LRRC24 PCBP1 ICAM5 TP53BP1

4.17e-0596335728671696
Pubmed

Progression of vertebrate limb development through SHH-mediated counteraction of GLI3.

GLI1 ALX4

4.40e-051035212215652
Pubmed

A Damage-Independent Role for 53BP1 that Impacts Break Order and Igh Architecture during Class Switch Recombination.

KMT5B TP53BP1

4.40e-051035227320916
Pubmed

Function and regulation of Alx4 in limb development: complex genetic interactions with Gli3 and Shh.

GLI1 ALX4

4.40e-051035216039644
Pubmed

Neogenin regulates Sonic Hedgehog pathway activity during digit patterning.

GLI1 ALX4

4.40e-051035222275192
Pubmed

A novel pro-Arg motif recognized by WW domains.

KMT2B PCBP1

4.40e-051035210744724
Pubmed

Fgf-dependent Etv4/5 activity is required for posterior restriction of Sonic Hedgehog and promoting outgrowth of the vertebrate limb.

GLI1 ALX4

5.38e-051135219386268
Pubmed

Combined genetic-pharmacologic inactivation of tightly linked ADAMTS proteases in temporally specific windows uncovers distinct roles for versican proteolysis and glypican-6 in cardiac development.

GLI1 ACAN

5.38e-051135238750698
Pubmed

SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.

ARID1A SS18

6.45e-051235211734557
Pubmed

Ptch2 shares overlapping functions with Ptch1 in Smo regulation and limb development.

GLI1 ALX4

7.62e-051335225448692
Pubmed

NFAT5/TonEBP controls early acquisition of notochord phenotypic markers, collagen composition, and sonic hedgehog signaling during mouse intervertebral disc embryogenesis.

GLI1 ACAN

7.62e-051335231301300
Pubmed

Sufu and Kif7 in limb patterning and development.

GLI1 ALX4

8.89e-051435225581370
Pubmed

Sonic hedgehog signaling directly targets Hyaluronic Acid Synthase 2, an essential regulator of phalangeal joint patterning.

GLI1 ACAN

8.89e-051435223313125
Pubmed

Genetic interaction between Gli3 and Ezh2 during limb pattern formation.

GLI1 ALX4

8.89e-051435229729398
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

AKNA TNRC18 KMT2B ARID1A LRRC24 EML3 GLI1

9.89e-05110535735748872
Pubmed

Twist1 activity thresholds define multiple functions in limb development.

GLI1 ALX4

1.02e-041535220732316
Pubmed

Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.

ARID1A SS18

1.02e-041535223785148
Pubmed

Synovial joint morphogenesis requires the chondrogenic action of Sox5 and Sox6 in growth plate and articular cartilage.

GLI1 ACAN

1.02e-041535220206616
Pubmed

Enpp1 inhibits ectopic joint calcification and maintains articular chondrocytes by repressing hedgehog signaling.

GLI1 ACAN

1.17e-041635230111653
Pubmed

Bmp4 in limb bud mesoderm regulates digit pattern by controlling AER development.

GLI1 ALX4

1.17e-041635215581864
Pubmed

The collagen receptor, discoidin domain receptor 2, functions in Gli1-positive skeletal progenitors and chondrocytes to control bone development.

GLI1 ACAN

1.17e-041635235140200
Pubmed

A switch from low to high Shh activity regulates establishment of limb progenitors and signaling centers.

GLI1 ALX4

1.17e-041635224726283
Pubmed

Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb.

GLI1 ALX4

1.17e-041635221795281
Pubmed

Chondroitin sulfate synthase 1 (Chsy1) is required for bone development and digit patterning.

GLI1 ACAN

1.33e-041735222280990
Pubmed

Formation of proximal and anterior limb skeleton requires early function of Irx3 and Irx5 and is negatively regulated by Shh signaling.

GLI1 ALX4

1.33e-041735224726282
Pubmed

Intracellular biosynthesis of lipids and cholesterol by Scap and Insig in mesenchymal cells regulates long bone growth and chondrocyte homeostasis.

GLI1 ACAN

1.49e-041835229899135
Pubmed

Distinct populations within Isl1 lineages contribute to appendicular and facial skeletogenesis through the β-catenin pathway.

GLI1 ALX4

1.49e-041835224424161
Pubmed

Distinct roles of Hand2 in initiating polarity and posterior Shh expression during the onset of mouse limb bud development.

GLI1 ALX4

1.49e-041835220386744
Pubmed

PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.

KMT2B TP53BP1

1.49e-041835217500065
Pubmed

Gata6-Dependent GLI3 Repressor Function is Essential in Anterior Limb Progenitor Cells for Proper Limb Development.

GLI1 ALX4

1.49e-041835227352137
Pubmed

Creb5 coordinates synovial joint formation with the genesis of articular cartilage.

ACAN CREB5

1.66e-041935236435829
Pubmed

Hox5 interacts with Plzf to restrict Shh expression in the developing forelimb.

GLI1 ALX4

1.85e-042035224218595
Pubmed

Growth arrest specific gene 1 acts as a region-specific mediator of the Fgf10/Fgf8 regulatory loop in the limb.

GLI1 ALX4

2.04e-042135212399319
Pubmed

Chromatin remodeler Arid1a regulates subplate neuron identity and wiring of cortical connectivity.

ARID1A ACAN

2.04e-042135234011608
Pubmed

FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds.

GLI1 ALX4

2.04e-042135219386269
Pubmed

Twist plays an essential role in FGF and SHH signal transduction during mouse limb development.

GLI1 ALX4

2.04e-042135212142027
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

KMT2B ARID1A PCBP1 ICAM5 TP53BP1

2.11e-0454935538280479
Pubmed

ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesis.

GLI1 TP53BP1

2.24e-042235225294941
Pubmed

Tcf/Lef repressors differentially regulate Shh-Gli target gene activation thresholds to generate progenitor patterning in the developing CNS.

TCF3 GLI1

2.24e-042235221775418
Pubmed

Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression.

GLI1 ALX4

2.46e-042335216672333
Pubmed

FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

ARID1A SS18

2.46e-042335230962207
Pubmed

Anti-osteogenic function of a LIM-homeodomain transcription factor LMX1B is essential to early patterning of the calvaria.

GLI1 ACAN

2.68e-042435229852132
Pubmed

The formation of the thumb requires direct modulation of Gli3 transcription by Hoxa13.

GLI1 ALX4

2.68e-042435231896583
Pubmed

A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets.

CELF4 TP53BP1

2.91e-042535221536733
Pubmed

Islet1 regulates establishment of the posterior hindlimb field upstream of the Hand2-Shh morphoregulatory gene network in mouse embryos.

GLI1 ALX4

2.91e-042535222438573
Pubmed

Genes and microRNAs associated with mouse cleft palate: A systematic review and bioinformatics analysis.

ACAN ALX4

2.91e-042535229475039
Pubmed

Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.

GLI1 RXRG TP53BP1

3.06e-0413035319386638
Pubmed

Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.

EML3 TP53BP1

3.15e-042635224067654
Pubmed

GATA6 is a crucial regulator of Shh in the limb bud.

GLI1 ALX4

3.15e-042635224415953
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

TNRC18 ARID1A SS18 KHDC4

3.38e-0433235437433992
Pubmed

Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.

ARID1A SS18

3.40e-042735229374058
Pubmed

Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis.

TCF3 ACAN

3.40e-042735223824573
Pubmed

Acentriolar mitosis activates a p53-dependent apoptosis pathway in the mouse embryo.

GLI1 TP53BP1

3.40e-042735224706806
Pubmed

Genetic loci influencing natural variations in femoral bone morphometry in mice.

ACAN ALX4

3.40e-042735211518254
Pubmed

Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development.

GLI1 ACAN

3.66e-042835221820362
Pubmed

Genetic mapping of eight SH3 domain genes on seven mouse chromosomes.

SORBS1 ACAN

3.66e-042835210087302
Pubmed

Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.

TCF3 SORBS1 GLI1

3.80e-0414035326930384
Pubmed

Anteroposterior Limb Skeletal Patterning Requires the Bifunctional Action of SWI/SNF Chromatin Remodeling Complex in Hedgehog Pathway.

GLI1 ALX4

3.93e-042935226959361
Pubmed

SMAD4 target genes are part of a transcriptional network that integrates the response to BMP and SHH signaling during early limb bud patterning.

GLI1 ALX4

3.93e-042935234822715
Pubmed

Evc works in chondrocytes and osteoblasts to regulate multiple aspects of growth plate development in the appendicular skeleton and cranial base.

GLI1 ACAN

4.20e-043035221911092
Pubmed

Voltage-gated potassium channel genes are clustered in paralogous regions of the mouse genome.

KCNA6 GLI1

4.49e-04313528034307
Pubmed

Expansion of the piriform cortex contributes to corticothalamic pathfinding defects in Gli3 conditional mutants.

GLI1 ACAN

4.49e-043135224014668
Pubmed

Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.

ARID1A SYT12 KHDC4 TP53BP1

4.54e-0435935435559673
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

PHYHIP SORBS1 KRT76 ARID1A LZTS3 PCBP1 ICAM5

4.81e-04143135737142655
Pubmed

Polycomb-Mediated Repression and Sonic Hedgehog Signaling Interact to Regulate Merkel Cell Specification during Skin Development.

TCF3 GLI1

5.09e-043335227414999
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

KMT2B ARID1A SS18

5.31e-0415735330186101
Pubmed

Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo.

GLI1 ALX4

5.41e-043435212086465
Pubmed

Protein-protein interaction panel using mouse full-length cDNAs.

TCF3 PCBP1 SS18

5.72e-0416135311591653
Pubmed

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.

TCF3 ARID1A GLI1 ALX4 RXRG

6.79e-0470935522988430
Pubmed

MTG8 interacts with LHX6 to specify cortical interneuron subtype identity.

GLI1 RXRG

7.12e-043935236064547
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

TCF3 TNRC18 KMT2B ARID1A KHDC4 TP53BP1

7.41e-04110335634189442
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

PCSK7 MMP7 KMT2B ARID1A TENT4A

7.74e-0473035534857952
Pubmed

Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.

SORBS1 LZTS3 PCBP1 ACAN

8.91e-0443035432581705
Cytoband11q13.2

SYT12 KMT5B

5.97e-044735211q13.2
Cytoband15q26.1

NGRN ACAN

7.88e-045435215q26.1
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

KMT2B KMT5B

1.00e-0334252487
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP LZTS3 ICAM5 RXRG

1.23e-05182354d41ff834b8fc1d0e23cac7ae261de5f72874e462
ToppCellfacs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP LZTS3 ICAM5 RXRG

1.23e-051823546cde859edfe7607bd7ada89d20258413d06f4207
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PHYHIP SORBS1 ACAN CREB5

1.28e-051843547b5678718719020b52e7c2a7bd9797987defd7ff
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PHYHIP SORBS1 ACAN CREB5

1.28e-0518435454e5b63f55b8d6eccad53d389ea9c78f991e1414
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 GLI1 RXRG

1.31e-0518535411c147f3f5570c4761d2bcff3bad28146b4a5861
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-27|World / Primary Cells by Cluster

ZNF711 NGRN CELF4 LRRC24

1.52e-05192354cf989f26c0ebdc0cd12e1e41958f063e4fa3e468
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC21 TMEM125 MMP7 ICAM5

1.58e-051943545b29c843186c2394f5bec3b1d5ae284a0d931d85
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC21 TMEM125 MMP7 ICAM5

1.58e-051943548c6e5ba27a988e0cd6b8c25cb9a30a0da2b1f7f9
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC21 TMEM125 MMP7 ICAM5

1.58e-051943546e78e3046c5b172af92a84e25f982377a0aaac58
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC21 TMEM125 MMP7 ICAM5

1.58e-05194354ebcf6c6d0eb20a5d422becf5a730089230c8ba9a
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster

PHYHIP NGRN CELF4 LRRC24

1.68e-0519735441e823b14697827f657b13adb3afa581bd91a9cb
ToppCellGlobus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PHYHIP ICAM5 RXRG

2.66e-04160353f843287ed57d2d5a3b3f6dfb03b6934e330e6645
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

PHYHIP ICAM5 RXRG

2.71e-04161353ebcd5066e82b7760b9da6adc02d11258d1309dab
ToppCellmild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2)

SORBS1 SYT12 ICAM5

3.01e-04167353bf08f17965a4dd03f371b4ed0ab0d5e62ed61307
ToppCellfacs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SH3BP1 AKNA PCSK7

3.07e-04168353182f08106ac65ea501e2fb9139d3b44b7c4662c9
ToppCellNS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PHYHIP ENOSF1 KHDC4

3.28e-04172353c0b5e4889aef2f168d9f6db19a63b24bfd249316
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TCF3 KCNA6 CREB5

3.34e-04173353e944ea3a0a368f856efacbda4600605cf751dd9c
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TCF3 KCNA6 CREB5

3.34e-0417335385fa5918e9c1f6bb4757e3350cfc71ee75c55640
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SORBS1 LZTS3 KHDC4

3.45e-04175353e99e145a152f534b75267ec492a252a0b814b4f8
ToppCellfacs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KCNA6 SYT12 ACAN

3.51e-0417635377c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCelldroplet-Bladder-nan-24m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCNA6 ALX4 RXRG

3.69e-041793533d6bb3cfe89d60f2f00aead9341f9967e5313763
ToppCellTCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9

SORBS1 CELF4 RXRG

3.69e-04179353431e1b29015ec817f778499106d24b19cfc825ae
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

LZTS3 SYT12 CREB5

3.75e-04180353c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PCSK7 SORBS1 MMP7

3.81e-04181353beb2771820956be8b190c0088ae3c4efdb53c897
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

3.87e-04182353d568a8aec7e27ce632e248baea2ccd0e8dd255ac
ToppCelldroplet-Limb_Muscle-MUSCLE-1m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

3.87e-04182353e89cc30db8e5c77a8bbddd1d5a4b5af09f1ccd67
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KCNA6 ACAN RXRG

3.87e-04182353a1c0e4090a9e7aa4941a40c817d178de144888b6
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

3.94e-041833535472cdce6d99314d229418412acf1fff6340db7d
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.00e-041843535939527d24d299e562e707469c9123890edd76be
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.00e-04184353a2191dd5546efd357b23e625beb3c5820476f243
ToppCelldroplet-Limb_Muscle-nan-21m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.00e-041843539f8cd5ab5af6c35a1be25d70a125b9a3f4dd667a
ToppCelldroplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.06e-041853533d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PHYHIP GLI1 CREB5

4.06e-041853539faa35ceb89ccd2979072286f063687c9f846ce3
ToppCelldroplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.06e-04185353995a8ddc3fd8e6879d8b5de8cbdefe232d34833b
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.06e-04185353b5277190866d9eb5b85eceaa5ba116ea6e6f286b
ToppCelldroplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCNA6 ALX4 RXRG

4.06e-04185353ca69499ba8c39b7ed6717d05685d6f70066a77bd
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.06e-041853531d731d69d8db8aef4a11439b8abd1030c7e6ac4c
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.06e-04185353b8d02c9426740ffcb69d2e6f95473b388149d297
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.13e-0418635390eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b
ToppCellfacs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP CELF4 SYT12

4.13e-04186353d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.13e-04186353d8d559daff4aeef334d403fde4e3ee2e4a6086d0
ToppCellILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SORBS1 GLI1 RXRG

4.13e-04186353cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.13e-04186353bd8a9753df219084e19e7f94447856e86608325c
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SORBS1 KCNA6 RXRG

4.19e-041873538e8b147258982b359447add5027318f5b6d51963
ToppCellPrimary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.19e-0418735397e520705491c8f52a32025311a9fa7b9176979a
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.19e-04187353b71d0cd91bc98e020757c1d071a13ad48d718bcf
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.19e-04187353f0de86ef25e344d9b1860ee26308877d6c25ed31
ToppCellprimary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.26e-04188353b04fd6a724c117eb9a979c29b91f90113feb7a5c
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.26e-0418835314072d0b82df55711d5356b2209f4f0bdd90dc27
ToppCellSomatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.26e-0418835360242c29c7f16c94a84685d3bc4ed93a66e70152
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.26e-041883533b8b9161f0fdcbde302ce5b4c0bc874628211109
ToppCelldroplet-Heart-HEART-1m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KCNA6 ALX4 RXRG

4.26e-04188353921a2c9212a0f2a00fd72c594d80924f27e8b9b7
ToppCelldroplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SORBS1 KCNA6 RXRG

4.26e-04188353502045a39ffb1e92bd9499848368e8fa971edb88
ToppCelldroplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.26e-04188353c2101ded71fb16b8ddbc1f883911b1ed2a533ffc
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.33e-0418935370eea8c94fa56bb15bee8065de47acea156794e9
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP ICAM5 RXRG

4.33e-04189353851f8144aed5c7f80302911cd6b03f14bde7b56d
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP ICAM5 RXRG

4.33e-041893533e8e30160a8d6f531ff743cb5918c9e79481f1bd
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.33e-04189353b60c8a29d3169c4830fe63b01db90c57660fc239
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.39e-04190353ff3dec5b45c6ea9b5319fb51a0198c6773b7be26
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP ICAM5 RXRG

4.39e-041903531c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc
ToppCellFetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SORBS1 ACAN CREB5

4.39e-04190353d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SORBS1 KCNA6 RXRG

4.39e-041903534971857eac9af17d66d673ed2ab7072639f60a10
ToppCellMid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ENOSF1 TMEM125 CREB5

4.46e-041913532110a1dd10730ad7ee7a265fb1716ab3ddafcf4a
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP CELF4 ICAM5

4.60e-04193353be28070c049e7cb68bcd54f582226eb2f5e4bc1c
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

ACAN ALX4 RXRG

4.60e-04193353b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PCSK7 SORBS1 ACAN

4.60e-041933535ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

ACAN ALX4 RXRG

4.60e-04193353e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP CELF4 ICAM5

4.60e-041933530c652ebe22ce5d2927599dd97ef1920547858395
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHYHIP CELF4 ICAM5

4.60e-041933538689a70a33a7c3823dc647d41ac0160e7c3ae396
ToppCell368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

PCSK7 SORBS1 ACAN

4.60e-041933535260ac95a15cc43a19909badad0c7e3854da920d
ToppCellILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SORBS1 GLI1 RXRG

4.60e-04193353084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCellFibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id

PCSK7 SORBS1 ACAN

4.74e-04195353c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1
ToppCellILEUM-non-inflamed-(9)_Neuro_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SORBS1 CREB5 RXRG

4.81e-041963532b08cd6730119d5dea0152709ab8de580b66cd3c
ToppCelldistal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ZNF711 SYT12 ICAM5

4.81e-0419635377635a0f86910c4019d3370e9c8ba41de176bcf3
ToppCellILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SORBS1 CREB5 RXRG

4.81e-04196353998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b
ToppCellControl-gd_T|Control / Disease condition and Cell class

AKNA PCSK7 KHDC4

4.88e-04197353000b3269c152d80527b5ad9412dd4e71b73ef1ca
ToppCell(3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis

KCNA6 GLI1 ACAN

4.88e-04197353a07ab2564ca7d577fd47f444dd7b0c25556e9fc4
ToppCellkidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TCF3 VPS13D MMP7

5.03e-04199353174f6013af6eafa577f84205a62927f2b367fda3
ToppCellBronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

SORBS1 ACAN RXRG

5.03e-041993532c5ad62919c64ea0242e0984bb9932d2d975f4e3
ToppCelldistal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MUC21 TMEM125 MMP7

5.03e-041993538f0a72a95d0310ef2324c6975495c294b5a47cc8
ToppCellBronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SORBS1 GLI1 ACAN

5.03e-0419935345c3b853900d8c3d5965117d904e3714100138bc
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

TMEM125 MMP7 ICAM5

5.03e-04199353a270630626df614f8605abddb7dee7c4d74f6149
ToppCellTracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PHYHIP SORBS1 GLI1

5.03e-041993539c2db0bb94cba71a3cc1827844da090e213e0258
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NGRN SORBS1 CREB5

5.03e-04199353a900ef002e1ae583b70be0253d8c44dae6754916
ToppCelldistal-Epithelial-Club|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MUC21 TMEM125 MMP7

5.03e-04199353c63ccce1285352927fd8c4f7374ec5fff8d70cec
ToppCellTracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PCSK7 SORBS1 ACAN

5.03e-04199353c2903b1a4b91e94bbdaa909bacefe901255cf248
ToppCelldistal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MUC21 TMEM125 MMP7

5.03e-04199353685cefbe6ff5db8b578e50b5849524ac2f347d0c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PHYHIP CELF4 RXRG

5.10e-042003532f481e2fd248c02a5aa2e0248c16808df142fed2
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PHYHIP CELF4 RXRG

5.10e-04200353dc674124475edf83908b51a4e1454bc2dc4f06fa
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PHYHIP CELF4 RXRG

5.10e-04200353bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d
ToppCellcontrol-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TNRC18 ARID1A CREB5

5.10e-04200353b5d197472799cc61d7497faed91ac2564ae4930a
ToppCellBiopsy_IPF-Epithelial-SCGB3A2+|Biopsy_IPF / Sample group, Lineage and Cell type

MUC21 TMEM125 MMP7

5.10e-042003532aaf130d702d18c277d16b6800f006a53ed653fb
ToppCellBrain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type.

CELF4 ALX4 CREB5

5.10e-042003532a635694844ddabcd98462c5636a6f41a3f08a46
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type

TMEM125 MMP7 ICAM5

5.10e-04200353eac33be484dc443794e66e473f03e98406c2983e
ToppCellBiopsy_Other_PF-Epithelial-SCGB3A2+|Biopsy_Other_PF / Sample group, Lineage and Cell type

MUC21 TMEM125 MMP7

5.10e-04200353631550dc34bcb605ab726645f4024d7828bb7975
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A

PCSK7 TCF3 ARID1A SS18 EML3

1.10e-051933551644_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

PCSK7 TCF3 KMT2B ARID1A EML3

1.15e-051953556927_DN
DrugNorfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A

ENOSF1 TCF3 VPS13D SS18 EML3

1.18e-051963552090_DN
DrugDroperidol [548-73-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A

PCSK7 TCF3 VPS13D SS18 EML3

1.24e-051983555690_DN
Drug2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A

VPS13D KMT2B ARID1A LZTS3 ACAN

1.24e-05198355347_DN
DrugTiclopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A

PCSK7 VPS13D KMT2B SS18 EML3

1.24e-051983554074_DN
DrugP-choline

PCSK7 GLI1

1.25e-0411352CID000124441
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

ENOSF1 VPS13D ARID1A PCBP1

1.43e-041743546579_DN
DrugRifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A

TCF3 ARID1A SYT12 EML3

1.78e-041843544349_DN
DrugTetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A

TCF3 LZTS3 SS18 EML3

2.01e-041903546769_DN
DrugMianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A

SORBS1 MMP7 ICAM5 ACAN

2.01e-041903545786_UP
Drug2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A

PCSK7 VPS13D ARID1A LZTS3

2.09e-041923543400_DN
DrugMoxalactam disodium salt [64953-12-4]; Down 200; 7uM; HL60; HT_HG-U133A

TCF3 VPS13D KMT2B EML3

2.13e-041933543028_DN
DrugVerapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A

ENOSF1 TCF3 VPS13D ARID1A

2.18e-041943542009_DN
DrugEquilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A

TCF3 VPS13D ARID1A LZTS3

2.18e-041943545620_DN
DrugPhthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A

ZNF711 PCSK7 SS18 EML3

2.22e-041953544653_DN
DrugMinaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; HL60; HG-U133A

TCF3 VPS13D SS18 ACAN

2.22e-041953541968_DN
DrugAtropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A

TCF3 VPS13D ARID1A LZTS3

2.22e-041953542761_DN
DrugS(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A

VPS13D SORBS1 EML3 CREB5

2.22e-041953546299_UP
DrugAmphotericin B [1397-89-3]; Up 200; 4.4uM; PC3; HT_HG-U133A

VPS13D ARID1A EML3 ACAN

2.22e-041953546303_UP
DrugDiperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A

PCSK7 VPS13D ARID1A ACAN

2.22e-041953541575_UP
DrugTetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A

PCSK7 TCF3 VPS13D SYT12

2.22e-041953546082_DN
DrugPregnenolone [145-13-1]; Down 200; 12.6uM; PC3; HT_HG-U133A

TCF3 VPS13D SORBS1 EML3

2.26e-041963544218_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A

ENOSF1 PCSK7 NGRN TCF3

2.26e-041963542035_DN
DrugMelatonin [73-31-4]; Down 200; 17.2uM; HL60; HT_HG-U133A

PCSK7 ARID1A LZTS3 ICAM5

2.26e-041963542431_DN
DrugChloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A

ZNF711 SYT12 SS18 EML3

2.26e-041963547251_UP
DrugNaringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A

ZNF711 ARID1A SYT12 CREB5

2.26e-041963545666_UP
DrugSulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HG-U133A

ENOSF1 PCSK7 VPS13D ACAN

2.26e-041963541913_UP
DrugCarbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A

KMT2B ARID1A LZTS3 EML3

2.26e-041963542437_DN
DrugLovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A

PCSK7 TCF3 VPS13D EML3

2.26e-041963544978_DN
DrugDienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A

TCF3 LZTS3 SS18 EML3

2.26e-041963543448_DN
Drugclozapine; Down 200; 10uM; MCF7; HT_HG-U133A

TCF3 VPS13D LZTS3 SYT12

2.31e-041973545226_DN
DrugMometasone furoate [83919-23-7]; Down 200; 7.6uM; HL60; HG-U133A

TCF3 ARID1A EML3 TP53BP1

2.31e-041973541746_DN
DrugAlprenolol hydrochloride [13707-88-5]; Up 200; 14uM; HL60; HG-U133A

ENOSF1 PCSK7 ARID1A ACAN

2.31e-041973541571_UP
DrugNaltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A

TCF3 VPS13D LZTS3 SYT12

2.31e-041973546241_UP
DrugPropidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A

SH3BP1 VPS13D SORBS1 ACAN

2.31e-041973542541_UP
DrugTriamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A

TCF3 KMT2B LZTS3 EML3

2.31e-041973541697_DN
DrugD-cycloserine [68-41-7]; Up 200; 39.2uM; HL60; HT_HG-U133A

SH3BP1 TCF3 MMP7 ALX4

2.35e-041983546139_UP
DrugTiabendazole [148-79-8]; Up 200; 19.8uM; HL60; HT_HG-U133A

PHYHIP TCF3 LZTS3 ALX4

2.35e-041983542479_UP
DrugTacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A

PCSK7 TCF3 ARID1A SS18

2.35e-041983542633_DN
Drug2-propylpentanoic acid; Down 200; 1000uM; MCF7; HG-U133A

ENOSF1 SS18 EML3 RXRG

2.35e-0419835423_DN
DrugAceclofenac [89796-99-6]; Down 200; 11.2uM; PC3; HT_HG-U133A

TCF3 KMT2B SS18 EML3

2.35e-041983542117_DN
DrugZidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A

ZNF711 TCF3 VPS13D ARID1A

2.35e-041983543211_UP
DrugNiacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A

KMT2B LZTS3 SYT12 EML3

2.40e-041993543381_DN
Drugradicicol; Down 200; 0.1uM; PC3; HG-U133A

VPS13D KMT2B EML3 ACAN

2.40e-04199354484_DN
DrugOleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HT_HG-U133A

PCSK7 TCF3 VPS13D SS18

2.40e-041993544615_DN
Drugestradiol, USP; Down 200; 0.1uM; MCF7; HG-U133A

VPS13D KMT2B EML3 GLI1

2.40e-04199354365_DN
DrugFurazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A

SORBS1 ARID1A ACAN ALX4

2.40e-041993543358_UP
Drugbeta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A

VPS13D ARID1A SYT12 EML3

2.40e-041993542819_DN
DrugEthosuximide [77-67-8]; Up 200; 28.4uM; HL60; HG-U133A

PCSK7 TCF3 LZTS3 EML3

2.40e-041993541433_UP
DrugIsoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A

PCSK7 TCF3 VPS13D KMT2B

2.40e-041993547211_DN
DrugAcemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A

VPS13D KMT2B ARID1A LZTS3

2.40e-041993546361_DN
Drugtetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A

ENOSF1 VPS13D ARID1A TP53BP1

2.40e-04199354498_DN
Drugsodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A

SH3BP1 PCSK7 TCF3 VPS13D

2.40e-04199354408_DN
Drug2-propylpentanoic acid; Down 200; 50uM; MCF7; HG-U133A

PCSK7 ARID1A LZTS3 ACAN

2.40e-04199354348_DN
DrugParoxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A

VPS13D KMT2B ARID1A LZTS3

2.44e-042003543904_DN
DrugLY294002; Up 200; 10uM; HL60; HG-U133A

PCSK7 VPS13D SS18 GLI1

2.44e-04200354361_UP
DrugHaloperidol [52-86-8]; Down 200; 10.6uM; HL60; HG-U133A

ENOSF1 PCSK7 TCF3 VPS13D

2.44e-042003542039_DN
Drugtert-amyl alcohol

PCSK7 MMP7

2.72e-0416352CID000006405
DrugCV-1

PCSK7 SS18 CREB5 RXRG

3.11e-04213354CID000130105
Diseasecholesterol to total lipids in IDL percentage

PCSK7 ARID1A TENT4A TP53BP1

7.71e-0760354EFO_0022233
Diseasecholesteryl esters to total lipids in IDL percentage

PCSK7 ARID1A TP53BP1

2.88e-0550353EFO_0022247
Diseasetriglycerides to phosphoglycerides ratio

PCSK7 ARID1A TP53BP1

7.27e-0568353EFO_0022327
DiseaseBurkitt Leukemia

TCF3 ARID1A

1.42e-0415352C4721444
DiseaseAfrican Burkitt's lymphoma

TCF3 ARID1A

1.42e-0415352C0343640
Diseaseliver volume

ARID1A TP53BP1

1.42e-0415352EFO_0600048
DiseaseMalignant neoplasm of breast

SORBS1 KRT76 TMEM125 ARID1A ICAM5 GLI1 TP53BP1

2.28e-041074357C0006142
Diseasecholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement

PCSK7 ARID1A TP53BP1

2.49e-04103353EFO_0008595, EFO_0020944
Diseasefree cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

PCSK7 ARID1A GLI1 TP53BP1

4.44e-04303354EFO_0004612, EFO_0020945
Diseasegastric adenocarcinoma (is_marker_for)

ARID1A ALX4

5.07e-0428352DOID:3717 (is_marker_for)
Diseasevery low density lipoprotein particle size measurement

PCSK7 ARID1A TP53BP1

5.27e-04133353EFO_0008594
DiseaseBurkitt Lymphoma

TCF3 ARID1A

8.40e-0436352C0006413
Diseasecolorectal cancer (is_marker_for)

TCF3 ARID1A GLI1

8.54e-04157353DOID:9256 (is_marker_for)
Diseasehepatocellular carcinoma (is_implicated_in)

KMT2B ARID1A ALX4

1.29e-03181353DOID:684 (is_implicated_in)
Diseasemultiple sclerosis (is_marker_for)

GLI1 ACAN

1.55e-0349352DOID:2377 (is_marker_for)
Diseasetriglycerides to total lipids in medium LDL percentage

TENT4A TP53BP1

1.62e-0350352EFO_0022334
Diseasetriglycerides to total lipids in large LDL percentage

TENT4A TP53BP1

1.68e-0351352EFO_0022331
Diseasesexual dimorphism measurement

PCSK7 KMT2B ARID1A ACAN CREB5 TP53BP1

1.75e-031106356EFO_0021796
Diseasetriglycerides in medium VLDL measurement

ARID1A TP53BP1

1.95e-0355352EFO_0022155
Diseasetriglycerides in very large VLDL measurement

ARID1A TP53BP1

2.02e-0356352EFO_0022325
Diseasetriglycerides in large VLDL measurement

ARID1A TP53BP1

2.02e-0356352EFO_0022178
Diseasefree cholesterol measurement, very low density lipoprotein cholesterol measurement

PCSK7 ARID1A TP53BP1

2.10e-03215353EFO_0008317, EFO_0008591
Diseasetriglycerides in VLDL measurement

ARID1A TP53BP1

2.24e-0359352EFO_0022326
Diseasevery low density lipoprotein cholesterol measurement, lipid measurement

PCSK7 ARID1A TP53BP1

2.24e-03220353EFO_0004529, EFO_0008317
Diseasecholesterol to total lipids in medium HDL percentage

PCSK7 TP53BP1

2.32e-0360352EFO_0022237
Diseasetriglycerides to total lipids in large HDL percentage

ARID1A TP53BP1

2.32e-0360352EFO_0022330
Diseasetotal lipids in VLDL measurement

ARID1A TP53BP1

2.32e-0360352EFO_0022314
Diseasetriglyceride measurement, very low density lipoprotein cholesterol measurement

PCSK7 ARID1A TP53BP1

2.36e-03224353EFO_0004530, EFO_0008317
Diseasetotal cholesterol measurement, very low density lipoprotein cholesterol measurement

PCSK7 ARID1A TP53BP1

2.36e-03224353EFO_0004574, EFO_0008317

Protein segments in the cluster

PeptideGeneStartEntry
SVSGAGSHVGQTHMG

ALX4

351

Q9H161
GSHVGQTHMGSLFGA

ALX4

356

Q9H161
GGSPGSHSHTTMANK

BARGIN

181

Q6ZT62
GLGGSPGSHSHTTMA

SH3BP1

171

Q9Y3L3
GGAGSISVSHSGMGS

KRT76

586

Q01546
RSHHAPMSPGSSGGG

ARID1A

356

O14497
GGAMTGPGTHQLSSA

CREB5

106

Q02930
MHGGTGFAGIDSSSP

PCBP1

251

Q15365
LGHSLGMGHSSDPNA

MMP7

216

P09237
GSSSSMGRPGHLGSG

LZTS3

286

O60299
GHSVSGSLLMPGHEA

NGRN

166

Q9NPE2
GSGTAALTGMHTTSH

MUC21

446

Q5SSG8
MGPHSDQGEHSGTVG

KMT5B

646

Q4FZB7
FPTSLGGHGADAMHT

ENOSF1

16

Q7L5Y1
GHTGTSAAAPLAAGM

PCSK7

401

Q16549
NSTLSVAGAMGSHGG

ICAM5

796

Q9UMF0
GLGGHSASDTGSGML

LRRC24

316

Q50LG9
SPGGSYGHLSIGTMS

GLI1

116

P08151
GAMGSSHGGPGDSSE

KMT2B

2011

Q9UMN6
SMKGSHGHTQGGGYS

TENT4A

716

Q5XG87
GAHSGAPDMSGEHSG

ACAN

1966

P16112
HGITPGEMGTGGSSS

KCNA6

236

P17658
SLEGHGNTSPMALGH

AKNA

151

Q7Z591
HGPIHMTNLGTGFSS

KHDC4

481

Q7Z7F0
PSRMYGGHGSHVTSV

EML3

831

Q32P44
HVIIGPSASGMGTTH

SYT12

386

Q8IV01
DNSGSHGSPTSGMLH

PHYHIP

166

Q92561
HGSPTSGMLHGVFFS

PHYHIP

171

Q92561
SPGSAGHMNGLSHSP

CELF4

26

Q9BZC1
GHMNGLSHSPGNPST

CELF4

31

Q9BZC1
VASGMGPSASSHGSP

TNRC18

71

O15417
GHGALASGFTGPMSL

TCF3

421

P15923
SHGSMGGYNHSVPSS

SS18

156

Q15532
SLHMNGDGGVHTPSS

SORBS1

1071

Q9BX66
GGSPGHTGSTSMSPS

RXRG

16

P48443
LSAMHSSGSSGKGAG

TP53BP1

1321

Q12888
MDSGGGSLGLHTPDS

ZNF711

1

Q9Y462
MATPSTHSGHGGHGS

TMEM125

181

Q96AQ2
TGTGMLAHEGSSVPH

VPS13D

3651

Q5THJ4